Sponsor Pipeline

Beijing Biostar Pharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
1
Recruiting
2
Phase 3
6
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07684456 Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2… Advanced Breast Cancer Not Yet Recruiting
Phase 2/3
NCT06841679 Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in… Gastric or Gastroesophageal Junction Adenocarcinoma Recruiting
Phase 2
NCT06683703 Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer… Non-small Cell Lung Cancer Patients with Brain Metastases Not Yet Recruiting
NCT06730581 Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors Gastric Cancer Adenocarcinoma Metastatic Not Yet Recruiting
NCT07044349 Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial… Ovarian Cancer Not Yet Recruiting
Phase 1
NCT05700084 Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid… Advanced Solid Tumor Active, Not Recruiting
Disease Areas
Get alerts when Beijing Biostar Pharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free